Medindia
Medindia LOGIN REGISTER
Advertisement

B. Braun Introduces WHIN(R) Safe Huber Needle

Wednesday, January 13, 2010 General News
Advertisement
Helps Protect Against Needle-stick Injuries, Blood and Fluid Exposure

BETHLEHEM, Pa., Jan. 13 -- B. Braun Medical Inc. (B. Braun) has launched its new safe and easy-to-use WHIN® Safe Huber Needle, an implantable port access device that integrates the features of two safety devices in a single Huber Needle and provides clinicians with advanced protection from needle-stick injuries and expelled blood and fluid.
Advertisement

(Logo: http://www.newscom.com/cgi-bin/prnh/20081022/NYW008LOGO )

There are three models of the WHIN® Safe Huber Needle -- a standard model, a model with a needle-free injection site and a model with an open Y-injection site. With an easy-to-dress and intuitive design, the device includes a safety shield that covers the needle tip as it is withdrawn, ensuring both clinician and patient safety.  
Advertisement

"The key to the WHIN® Safe Huber Needle is that it requires minimal change in technique on the part of clinicians," said Tom Sutton, Director of Marketing Vascular Access for B. Braun Medical Inc. "That means it can be immediately deployed to provide added measures of safety."

B. Braun's WHIN® Safe Huber Needle Web site, www.whinsafe.bbraunusa.com, provides information on the device as well as information on best practices for clinicians as part of B. Braun's "Sharing Expertise®" philosophy.

"The Web site offers clinicians a focused, easily accessible way to obtain product information as well as information on how the WHIN® Safe Huber Needle can enhance clinician and patient safety," added Sutton.

The WHIN® Safe Huber Needle is one product in a comprehensive line of safe, environmentally responsible B. Braun oncology infusion therapy products. These include pumps that enhance IV safety at home and in clinic settings; PVC-free and DEHP-free IV bags that reduce patient exposure to harmful plasticizers and help healthcare facilities meet their environmental objectives; IV sets and UV-resistant tubing; needle-free IV systems; and IV catheters and Huber needles. The WHIN® Safe Huber Needle will be offered to oncology outpatient centers, home infusion therapy and hospital-based oncology facilities.

B. Braun also adds value to its oncology infusion therapy product line with clinical analysis programs to improve patient and practitioner safety, clinical mentoring programs as well as programs for clinicians and pharmacists and 24/7 clinical and technical support.

About B. Braun

B. Braun is a leading manufacturer of infusion therapy and pain management products with an environmentally-friendly focus. Guided by the company's "Sharing Expertise®" philosophy, B. Braun addresses the critical issues of infection prevention, medication safety and environmental responsibility by promoting best practices that help clinicians reduce medication errors, prevent healthcare-acquired infections (HAIs) and achieve sustainability objectives.

Consistently recognized by Frost & Sullivan and KLAS for its medical technology and support services, B. Braun employees share their knowledge with colleagues and customers to improve working processes in hospitals and medical practices and to enhance the safety of patients and healthcare professionals. For more information, call 800-227-2862, e-mail us at [email protected] or visit B. Braun at www.bbraunusa.com.

SOURCE B. Braun Medical Inc.

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close